INTRODUCTION
Telomeres are complex nucleoprotein structures, which function to maintain and protect the ends of linear chromosomes. Mammalian telomeres are composed of tandem repeats of TTAGGG sequences, which terminate in a 3 0 single-stranded overhang (de Lange, 2005) . Telomere-repeat length can be maintained by the action of telomerase or by an alternative telomere length (ALT) maintenance mechanism that utilizes homologous recombination in 10% of cancer cells (Bryan et al., 1997; Greider and Blackburn, 1985) . Telomere function is also critically dependent on shelterin, a protein complex comprising telomerespecific binding proteins including TRF1, TRF2, and POT1 that function to regulate telomerase and protect the chromosome end (de Lange, 2005) .
Visualization of vertebrate telomeres by electron microscopy revealed that telomeres frequently adopt a lasso-like configuration called a T loop (Griffith et al., 1999) . T loop structures also exist in other eukaryotes (Cesare et al., 2003; Muñ oz-Jordá n et al., 2001; Raices et al., 2008) , and their formation requires both homologous recombination (HR) and shelterin components (Verdun and Karlseder, 2006) . The T loop is therefore believed to result from strand invasion of the 3 0 single-stranded telomeric end into subtelomeric duplex TTAGGG repeats, which results in a displacement loop (D loop) intermediate at the site of strand invasion (Amiard et al., 2007) . It has been proposed that T loops protect the chromosome end from degradation and promiscuous DNA-repair activities (de Lange, 2005) , but evidence that T loops form at all telomeres and perform a protective function is currently lacking. Irrespective of the nature of T loops, these structures must be removed to permit telomere replication, but the mechanistic basis of T loop disassembly remains unclear (Gilson and Gé li, 2007) .
Fragile sites are specific chromosomal loci that exhibit gaps or breaks when cells are subjected to low doses of aphidicolin, which induces replication stress (Durkin and Glover, 2007) . Fragile sites are hot spots for deletions and other chromosome rearrangements and are associated with an increased frequency of HR (Glover and Stein, 1987) . Recently, telomeres have been identified as aphidicolin-induced fragile sites (Sfeir et al., 2009 ). TRF1 and the DNA helicases RTEL1 and BLM are required to prevent telomere fragility, but how they do so is uncertain (Sfeir et al., 2009) . It was proposed that TRF1, RTEL1, and BLM may facilitate telomere replication by removing telomeric G-quadruplex (G4) DNA structures (Sfeir et al., 2009 ). However, the contribution of telomeric G4-DNA structures to telomere fragility has not been addressed.
RTEL1 (regulator of telomere length) is a helicase first identified by genomic mapping of loci that control telomere-length differences between M. musculus and M. spretus (Zhu et al., 1998) . RTEL1 plays an essential role in genome stability as knockout mice are embryonic lethal and cells derived from these mice exhibit impaired proliferation, chromosomal abnormalities, and telomere loss, but the molecular basis of this defect remains unclear (Ding et al., 2004) . RTEL1 was also recently identified in a genome-wide association study as a susceptibility locus for glioma, highlighting its importance for genome integrity (Egan et al., 2011; Shete et al., 2009) . RTEL1 was also independently identified as an antagonist of HR with functional similarity to the yeast antirecombinase Srs2 (Marini and Krejci, 2010) . Because human RTEL1 exhibits D loop dissociation activity in vitro, it was proposed that the phenotypes associated with RTEL-1/RTEL1 deficiency reflect a defect in dismantling recombination intermediates (Barber et al., 2008; Youds et al., 2010) , but how this function contributes to tumorigenesis is not known.
In this work, we have investigated the underlying cause of telomere dysfunction in RTEL1-deficient cells. We present evidence that RTEL1 is essential for the disassembly of T loops during DNA replication. Failure to dismantle T loops in RTEL1-deficient cells leads to rapid changes in telomere length and telomere loss as a result of catastrophic telomere processing by the SLX4 nuclease complex, which resolves the T loop as a circle. We define a general mechanism of telomere circle (TC) formation as we show that the SLX4 nuclease complex is also responsible for the formation of TCs that arise in ALT cells and in cells overexpressing the dominant-negative TRF2DB. Furthermore, we demonstrate that RTEL1 and BLM operate in genetically distinct pathways to counteract telomere fragility, and we establish that telomeric G4-DNA structures are a major source of telomere fragility in RTEL1-deficient cells. Thus, our findings define the mechanistic basis of T loop disassembly and provide insight into the source and prevention of telomere fragility, which reflect two distinct activities of RTEL1 at telomeres.
RESULTS

Conditional Deletion of RTEL1 Results in Telomere Abnormalities
To investigate the telomere function of mammalian RTEL1, we established a conditional allele of the mouse RTEL1 gene that permits Cre-mediated deletion of exon 7, resulting in the premature termination of the RTEL1 coding sequence (Wu et al., 2007) . Infection of RTEL1 F/À mouse embryonic fibroblasts (MEFs) with a Cre-expressing adenovirus resulted in the loss of the floxed RTEL1 allele and elimination of the RTEL1 protein within 72 hr ( Figures 1A and 1B) . Cre-mediated deletion of RTEL1 resulted in reduced proliferative capacity, induction of senescence, and accumulation of sister chromatid breaks on 11% of chromosomes per metaphase ( Figure S1 available online). Analysis of metaphases in RTEL1 F/À MEFs by telomere fluorescence in situ hybridization (FISH) 96 hr after Cre-infection also revealed various striking telomere abnormalities ( Figures 1C and S1 ). In wild-type (WT) cells, telomere FISH signals are present on each individual sister chromatid end, and the intensity of the FISH signal is comparable between each sister chromatid. Following conditional inactivation of RTEL1, the intensity of the telomere FISH signal was significantly reduced or increased on a given sister chromatid end relative to the other sister, suggestive of a rapid alteration in telomere length ( Figures 1C and 1D) . We also detected a high incidence of chromosomes in RTEL1 À/À cells that lacked a detectable telomere FISH signal on one or both sister chromatid ends, indicative of complete telomere loss ( Figures 1C and 1D ). In agreement with a recent report (Sfeir et al., 2009) , we also detected a high incidence of fragile telomeres following inactivation of RTEL1 that manifests as sister chromatid ends with multiple spatially separated telomere FISH signals ( Figures 1C and 1D ). Analysis of telomere length by quantitative telomere FISH confirmed that loss of RTEL1 leads to rapid alteration in the mean telomere length, which included a statistically significant increase in both short and long telomeres ( Figure 1E ) (Ding et al., 2004) . Because inactivation of either RTEL1 or TRF1 confers a fragile telomere phenotype (Sfeir et al., 2009 ), we performed a direct comparison of telomere phenotypes in conditional knockout MEFs. Inactivation of RTEL1 resulted in loss of the telomere FISH signal on 18 ± 2 chromosome ends per metaphase. This contrasted with the loss of less than 2 ± 1 telomeres per metaphase in RTEL1 +/À and TRF1 À/À cells ( Figure 1F ). Confirming a recent report, inactivation of either TRF1 or RTEL1 resulted in 17 ± 2 and 12 ± 3 fragile telomeres per metaphase, respectively ( Figure 1G ) (Sfeir et al., 2009 ). RTEL1-deficient cells also showed a significant induction of the DNA-damage response at telomeres, although this phenotype was not as strong as previously reported in TRF1-deficent cells ( Figure S1 ) (Sfeir et al., 2009) . Our data reveal that inactivation of RTEL1 results in the accumulation of several distinct telomere abnormalities, including rapid changes in telomere length, telomere loss, and telomere fragility. Although telomere fragility is a phenotype observed in both RTEL1-and TRF1-deficient cells (Sfeir et al., 2009) , the telomere-length heterogeneity and loss of telomeres are only seen following inactivation of RTEL1. This raises the possibility that the phenotype of RTEL1-deficient cells may reflect at least two distinct roles for RTEL1 at telomeres.
RTEL1 Can Disassemble T Loops In Vitro
RTEL1 was previously identified as an antirecombinase that acts to constrain HR by disassembling D loop intermediates (Barber et al., 2008) . We reasoned that the ability of RTEL1 to disassemble preformed D loops during conventional HR reactions may have been co-opted to dismantle T loop structures that are believed to form at telomeres when the 3 0 single-stranded end of the telomere invades into double-stranded telomere repeats to form a lasso-like structure (Griffith et al., 1999) , which contains a D loop at the site of strand invasion (de Lange, 2005) .
To determine whether RTEL1 is capable of disrupting a T loop structure in vitro, we employed a T loop assay developed by Verdun and Karlseder (Verdun and Karlseder, 2006) . In this assay, a radiolabeled telomere repeat fragment containing a single-stranded DNA end was shown to undergo strand invasion into a telomere repeat containing plasmid to form a T loop in the presence of cell extracts ( Figure S2A ). Critically, T loop formation required HR factors as well as the shelterin components TRF1 and TRF2 as their depletion from the extract abolished T loop formation in vitro (Verdun and Karlseder, 2006) . To determine whether RTEL1 impacts on T loop formation in this assay, we generated extracts from control cells and cells induced to express either the WT or the ATPase dead mutant (K48R) of RTEL1 ( Figure S2B ). T loop structures were readily detected as a slower-migrating band on agarose gels in control extracts (-Tet; Figure S2C , lanes 3 and 5) but not when either the extract or the plasmid substrate was omitted ( Figure S2C , lanes 1 and 2). Furthermore, T loops formed in cell extracts expressing the K48R mutant of RTEL1 ( Figure S2C , lane 6) but not in extracts expressing WT RTEL1 ( Figure S2C, lane 4) . Additionally, T loops only formed with telomere repeat fragments containing a 3 0 single-stranded end ( Figure S2C , lanes 3 to 6) but not with a 5 0 single-stranded end ( Figure S2C , lanes 7-10), which conforms to the physiological orientation of strand invasion by HR. These results demonstrate that RTEL1 can disassemble or prevent the formation of T loops in vitro, and this requires its ATPase activity. This finding raised the possibility that telomere loss in RTEL1-deficient cells may reflect a failure to efficiently dismantle T loops in vivo.
TCs Rapidly Accumulate following Inactivation of RTEL1
We speculated that the rapid loss of telomeres in the absence of RTEL1 could arise if persistent T loops were inappropriately processed to produce a TC. Previous studies have shown that TCs form at a high frequency in cells that overexpress the dominantnegative TRF2DB and also in ALT cells, which maintained telomeres by recombination in the absence of telomerase (Henson et al., 2009; Wang et al., 2004) . To determine whether TCs also accumulate following inactivation of RTEL1, we developed a TC amplification assay based on a previous method used to detect TCs in plants (Zellinger et al., 2007) . In this assay, a telomere-specific oligonucleotide is annealed with denatured genomic DNA and subject to rolling circle amplification by Phi29 polymerase. The amplified telomere products are resolved on denaturing gels and detected by telomere repeat Southern blot ( Figure 2A ). The product of TC amplification can be distinguished from linear telomere repeat fragments (TRFs) by the fact that TRFs are significantly retarded on gel (Zellinger et al., 2007) . Specificity of the TC amplification is based on the resistance of circular DNA to treatment with exonuclease V (ExoV) compared to linear TRFs that are degraded by ExoV (Zellinger et al., 2007) . As a proof of principle, we used the TC amplification assay on TRF2DB-overexpressing cells and in VA13 ALT cells, (F and G) Quantification of (F) telomere loss and (G) telomere fragility per metaphase before and 96 hr post Cre-treatment in MEFs of the indicated genotype.Error bars indicate ± standard error of the mean (SEM) from at least 50 metaphases. See also Figure S1 .
which confirmed the presence of TCs as previously reported ( Figure 2B ) (Henson et al., 2009; Wang et al., 2004) . To determine whether telomere loss in RTEL1-deficient cells correlates with the accumulation of TCs, we employed the TC amplification assay on conditional RTEL1 F/À MEFs. A low basal level of Phi29-dependent TCs was detected in untreated RTEL1 F/À cells. In contrast, very high levels of Phi29-dependent TCs were detected in RTEL1-deficient cells 96 hr post-treatment with Cre ( Figure 2C ). Importantly, incubation of genomic DNA with ExoV prior to Phi29 rolling circle amplification abolished the linear TRF signal but had no effect on TCs, confirming that the amplified products arise from circular species ( Figure 2D ). To examine the dynamics of TC formation following inactivation of RTEL1, we performed a time course analysis following RTEL1 inactivation. Phi29-dependent TCs were readily detected 24 hr after Cre-infection of RTEL1 F/À cells and increased progressively up to 96 hr after Cre-infection to levels exceeding those observed in VA13 ALT cells, which acted as a positive control ( Figure 2E ). Thus, TCs rapidly accumulate following inactivation of RTEL1, which suggests that telomere loss results from excision of the telomere as a circle within two to three cell cycles.
Inhibiting DNA Replication Exacerbates Telomere Fragility but Blocks TC Formation and Telomere Loss in RTEL1-Deficient Cells
The fragile telomeres that accumulate in TRF1-deficient cells resemble common fragile sites as both events are respectively increased and induced following treatment with aphidicolin, which inhibits DNA polymerase and blocks replication (Durkin and Glover, 2007; Sfeir et al., 2009) . To examine the impact of replication inhibition on the telomere phenotype of RTEL1-deficient cells, we examined metaphases of RTEL1-proficient and -deficient MEFs treated with a low concentration of aphidicolin (0.2 mM). Aphidicolin treatment led to a modest induction of telomere fragility in RTEL1-proficient cells (Sfeir et al., 2009 ) and a substantial increase in the number of fragile telomeres in RTEL1-deficient cells, corresponding to an increase from 11 ± 3 fragile telomeres per metaphase showing fragility without treatment to 21 ± 2 following treatment with aphidicolin ( Figure 3A ). These results suggest that the fragile telomeres arising following inactivation of RTEL1 resemble common fragile sites, as is the case in TRF1-deficient cells (Sfeir et al., 2009) .
To investigate the impact of replication inhibition on the accumulation of TCs in RTEL1-deficient cells, we examined TC formation in RTEL1-proficient and -deficient cells following treatment with aphidicolin. Strikingly, aphidicolin treatment (5 mM) completely abolished Phi29-dependent TC amplification following inactivation of RTEL1 ( Figure 3B ). TC formation was also abolished in RTEL1-deficient cells following treatment either with a lower concentration of aphidicolin (0.5 mM) or with hydroxyurea (3 mM), which stalls replication by inhibition of ribonucleotide reductase ( Figure 3C ). If telomere loss in RTEL1-deficient cells results from excision of the T loop as a circle then aphidicolin treatment should also suppress the VA13 ALT cells were used as control for TC amplification. Error bars indicate ± SEM from at three independent experiments. See also Figure S2 .
frequency of telomere loss following RTEL1 inactivation. Indeed, aphidicolin treatment led to a substantial reduction in the frequency of telomere loss in RTEL1-deficient cells, corresponding to a statistically significant (p < 0.05) reduction from 12 ± 5 telomere loss per metaphase in untreated RTEL1 À/À cells to 4.5 ± 1.8 telomere loss per metaphase following treatment with aphidicolin, which is comparable to the telomere loss observed in RTEL1-proficient cells ( Figure 3D ). These results suggest that loss of telomeres in RTEL1-deficient cells results from excision of the telomere as a circle, which requires active DNA replication.
TC Formation and Telomere Loss in RTEL1-Deficient Cells Are SLX4 Dependent
We next focused our efforts toward understanding the mechanism of TC formation and telomere loss in RTEL1 null cells. We reasoned that a persistent T loop could be cleaved at the site of strand invasion by a structure-specific nuclease and repaired as a crossover, which would result in loss of the telomere as a circle. Intriguingly, the human SLX4 nuclease complex was recently shown to associate with telomeres based on proteomics of isolated chromatin (PICh) segments data (Dé jardin and Kingston, 2009), its interaction with the shelterin components Rap1 and TRF2 (Fekairi et al., 2009; Svendsen et al., 2009) , and its colocalization with Rap1 at telomeres in immunofluorescence (IF) experiments (Svendsen et al., 2009) . Moreover, biochemical studies have established that the SLX4 nuclease complex exhibits resolution activity toward D loop and Holliday junction intermediates that are believed to form at the site of strand invasion of the T loop (Fekairi et al., 2009; Muñ oz et al., 2009; Svendsen et al., 2009 ). Thus, the SLX4 nuclease complex is located at telomeres and possesses the appropriate nucleolytic activity to excise the T loop as a circle in RTEL1-deficient cells.
To test this possibility, we first assessed the contribution of the SLX4 subunit of this complex, which is believed to function as a scaffold protein that binds directly to each of the three nucleases in the complex (MUS81, XPF, and SLX1) (Svendsen and Harper, 2010) . Strikingly, TC formation was completely abolished in RTEL1 À/À MEFs stably expressing SLX4 shRNA but not with control shRNA (Figures 4A and 4B) . Importantly, analysis of cell-cycle profiles of these cells excluded that the effect of SLX4 depletion on TC formation is an indirect consequence of a block to DNA replication ( Figure S3A ). To determine whether the suppression of TC formation in RTEL1-deficient cells also rescues telomere loss and to exclude potential off-target effects of SLX4 shRNA, we analyzed metaphase spreads in RTEL1-proficient and -deficient cells expressing two different SLX4 shRNAs ( Figure S4, sh1 and 2 ). In RTEL1-proficient cells (ÀCre), stable knockdown of SLX4 had no measurable effect on telomere loss ( Figure 4C ). In agreement with our previous results, RTEL1-deficient cells treated with control shRNA exhibited a high frequency of telomere loss (+Cre: 19 ± 6.7 telomere loss per metaphase) when compared to RTEL1-proficient cells (ÀCre: 3.3 ± 1.3 telomere loss per metaphase). In contrast, stable knockdown of SLX4 in RTEL1-deficient cells resulted in a striking suppression of the telomere loss phenotype ( Figure 4C ). Analysis of telomere length by quantitative telomere FISH revealed that SLX4 knockdown also suppressed the increase in both short and long telomeres in RTEL1-deficient cells ( Figure S3B ). However, SLX4 knockdown neither induced telomere fragility alone nor rescued the fragile telomere phenotype of RTEL1 À/À cells ( Figure 4D ). These results demonstrate that SLX4 is required for TC formation and telomere loss in RTEL1-deficient cells, but it has no measurable effect on telomere fragility.
To determine whether our findings reflect a general mechanism of TC formation, we next assessed whether active DNA replication and the SLX4 complex are also required for TC formation in ALT cells or TRF2DB-overexpressing cells, which also accumulate TCs ( Figure 2B ) (Henson et al., 2009; Wang et al., 2004) . Treatment of VA13 ALT cells with 0.5 mM aphidicolin completely suppressed TC formation ( Figure S5A) . Moreover, the stable knockdown of SLX4 in VA13 ALT with four different shRNAs (sh1-4) resulted in a substantial decrease in TCs when compared to VA13 ALT cells expressing a control shRNA (Figure S5A ). In agreement with previous data, overexpression of TRF2DB, but not WT TRF2, in NIH 3T3 cells induced high levels of TCs (Wang et al., 2004) . Treatment of TRF2DB-overexpressing cells with 0.5 mM aphidicolin or stable expression of SLX4 shRNA led to a marked reduction in the level of TCs ( Figure S5B ). These results establish that TC formation in ALT cells, RTEL1-deficient cells, or cells overexpressing TRF2DB occurs by a common mechanism that requires active DNA replication and the SLX4 nuclease complex. MEFs stably expressing two different shRNAs to SLX1 or to ERCC1 exhibited markedly decreased levels of TCs, which was comparable to the suppression of TCs observed in RTEL1-deficient cells subjected to SLX4 shRNA knockdown ( Figures 5B and 5C ). To confirm these results, we also assessed telomere loss in RTEL1-deficient cells. Knockdown of either SLX1 or ERCC1 resulted in a substantial rescue of the telomere loss phenotype in RTEL1-deficient MEFs ( Figure 5D ). However, SLX1 or ERCC1 knockdown failed to rescue the fragile telomere phenotype of RTEL1 À/À cells ( Figure 5E ). These results demonstrate that the SLX4-associated nucleases SLX1 and ERCC1/ XPF both contribute to the formation of TCs and the resultant loss of telomeres in RTEL1-deficient cells, but like SLX4, neither nuclease has an impact on telomere fragility.
Telomere Fragility, but Not Telomere Loss, in RTEL1-Deficient Cells Is Exacerbated by Loss of BLM A role for RTEL1 in controlling HR was first suggested by the synthetic lethality of rtel-1; him-6 (Sgs1/BLM) double mutants in C. elegans, which die as a result of the accumulation of toxic recombination intermediates (Barber et al., 2008) . Intriguingly, a recent study reported that knockdown of either BLM or RTEL1 results in telomere fragility in vertebrate cells (Sfeir et al., 2009 ), but whether or not BLM and RTEL1 function together or in genetically distinct pathways to avert telomere fragility was not addressed. We therefore generated RTEL1 (n°1) shSLX4 (n°2) shSLX1 (n°2) shSLX1 (n°1) shERCC1 (n°2) (B) Phi29-dependent TCs in RTEL1 À/À MEFs subjected to control, SLX4, SLX1, or ERCC1 shRNAs (two independent shRNAs for each: n 1 and n 2).
(C) Quantification of the fold induction of Phi29-dependent TCs in RTEL1 À/À MEFs subjected to control, SLX4, SLX1, or ERCC1 shRNAs.
(D) Quantification of telomere loss per metaphase in RTEL1 À/À MEFs subjected to control, SLX1, or ERCC1 shRNAs (significance: one-way ANOVA, p < 0.05).
Error bars indicate ± SEM from at least 50 metaphases.
(E) Quantification of fragile telomeres per metaphase in RTEL1 À/À MEFs subjected to control, SLX1, or ERCC1 shRNAs (significance: one-way ANOVA, p < 0.05).
Error bars indicate ± SEM from at least 50 metaphases. See also Figure S5 .
suggesting that BLM does not significantly contribute to T loop disassembly ( Figure 6A ). In agreement with previous data, loss of either BLM or RTEL1 resulted in enhanced telomere fragility (15 ± 6.4 and 17 ± 7.2 fragile telomeres per metaphase, respectively, compared to 5.2 ± 2.9 in controls; Figure 6C ) (Sfeir et al., 2009) . Strikingly, RTEL1 À/À BLM À/À double-knockout cells displayed an additive effect on telomere fragility, corresponding to 28 ± 15 fragile telomeres per metaphase ( Figure 6C ). Further analysis of metaphase spreads of BLM-deficient cells revealed a low frequency of telomere loss relative to cells lacking RTEL1, which corresponded to an average of 3.1 ± 1.6 telomere loss per metaphase in BLM À/À MEFs and 12 ± 5.2 in RTEL1 À/À MEFs ( Figure 6B ). In contrast to the additive effect on telomere fragility, the levels of telomere loss in RTEL1 À/À BLM À/À double-knockout cells were not statistically different from those in RTEL1-deficient cells (average of 13 ± 5.2 telomere loss in RTEL1 À/À BLM À/À MEFs compared with 12 ± 5.2 in RTEL1 À/À MEFs; Figure 6B ). These results suggest that RTEL1 and BLM function in distinct pathways to suppress telomere fragility. Moreover, BLM does not have a significant impact on telomere loss either alone or in combination with RTEL1.
Stabilization of G4-DNA Structures Exacerbates Telomere Fragility in RTEL1-Deficient Cells but Has No Impact on Telomere Loss
It has been speculated that telomere fragility reflects a problem replicating telomere repeats, which have been reported to adopt G4-DNA secondary structures that could hinder DNA replication (Gilson and Gé li, 2007; Sfeir et al., 2009 1999) and examined TC formation, telomere loss, and telomere fragility. Treatment of RTEL1-deficient cells with TMPyP4 (10 mM) had no measurable effect on TC formation, whereas treatment with aphidicolin (Apd, 5 mM) blocked TC formation ( Figure 6D ). Furthermore, telomere loss was comparable between untreated RTEL1-deficient cells and those treated with TMPyP4 ( Figure 6E ). Strikingly, however, TMPyP4 treatment resulted in a dramatic elevation in telomere fragility in RTEL1-deficient cells, corresponding to 31 ± 11 fragile telomeres per metaphase following TMPyP4 treatment compared to 20 ± 5.9 fragile telomeres per metaphase without treatment ( Figure 6F ).
Collectively, these results demonstrate that G4-DNA secondary structures are a major source of telomere fragility in the absence of RTEL1, but stabilization of these structures has no measurable impact on TC formation and telomere loss.
DISCUSSION
The existence of T loop structures at human telomeres was first described over a decade ago (Griffith et al., 1999) . Subsequent studies have confirmed that T loops also form in other species (Cesare et al., 2003; Muñ oz-Jordá n et al., 2001; Raices et al., 2008) , and investigation into the factors that promote T loop assembly revealed that this structure corresponds to a specialized HR intermediate formed by HR and shelterin components that catalyze strand invasion of the 3 0 single-stranded end of the telomere into proximal double-stranded telomere repeats (de Lange, 2005; Verdun and Karlseder, 2006 ). Here we establish that the helicase RTEL1 plays a critical role in the disassembly of T loops, and we provide mechanistic insight into the dramatic consequences of a failure to disassemble T loops effectively ( Figure 7A ). In addition to promoting T loop disassembly, we establish that RTEL1 performs a second distinct function required to avert telomere fragility caused by G4-DNA structures that form from telomere repeats ( Figure 7B ).
RTEL1 Dismantles T Loops to Prevent Catastrophic
Telomere Processing by the SLX4 Resolvasome RTEL1 was previously implicated as an antirecombinase that acts by disrupting D loops formed during HR (Barber et al., 2008) . During DNA repair, RTEL1 activity is employed to counteract toxic recombination intermediates, whereas in meiosis this activity is believed to promote synthesis-dependent strand annealing to limit crossing over (Barber et al., 2008; Youds et al., 2010) . Our current findings establish that the telomere loss and rapid changes in telomere length observed in RTEL1-deficient cells reflects a defect in the efficient disassembly of T loops. We propose that the D loop disruption activity of RTEL1 is required to displace the 3 0 end of the telomere to allow efficient unwinding of T loops ( Figure 7A ). Replication through telomeric G4-DNA structures
Telomere fragility In support of this hypothesis, we found that WT RTEL1, but not an ATPase-dead mutant, is able to antagonize the formation of a T loop structure formed in vitro. In vertebrate cells, we observed that conditional inactivation of RTEL1 results in the rapid accumulation of TCs, whose formation is coincident with rapid changes in telomere length and telomere loss. We attribute TC formation and telomere loss to the inappropriate resolution of the T loop as a circle as downregulation of SLX4 or its associated nucleases, SLX1 or ERCC1/XPF, rescues these phenotypes ( Figure 7A ). Previous studies have shown that the SLX4 nuclease complex is a Holliday junction-resolving enzyme that interacts with TRF2 and Rap1 and colocalizes with Rap1 at telomeres (Fekairi et al., 2009; Muñ oz et al., 2009; Svendsen et al., 2009 ). Our findings suggest that the resolution activity of the SLX4 nuclease complex resolves T loops that persist in the absence of RTEL1. Depending on the orientation of nucleolytic cleavage, processing of the T loop is predicted to result in a crossover and loss of the telomere as a circle (de Lange, 2005) . Double-strand breaks formed following incision of the T loop could also recombine with another telomere leading to telomere addition or loss (Wang et al., 2004) . Consistent with this hypothesis, RTEL1-deficient cells exhibit elevated telomere recombination frequencies, which manifest as telomere sister chromatid exchanges ( Figure S6 ).
Our observation that TC formation and telomere loss in RTEL1-deficient cells are suppressed by blocking DNA replication raises the possibility that persistent T loops are removed during S phase (Gilson and Gé li, 2007) . It is possible that resolution of persistent T loops in RTEL1 null cells is triggered by a collision between the T loop and the replisome. Alternatively, positive supercoiling in front of the advancing replication fork could result in a change in T loop conformation that ''opens up'' the telomere to allow access to the D loop, thus limiting access only when the telomere is replicated. In normal cells, we presume that RTEL1 accesses the T loop preferentially, but in the absence of RTEL1 or in the event that T loops persist in WT cells, the SLX4 nuclease complex gains access to the D loop, leading to resolution of the T loop as a circle. It is possible that RTEL1 is only transiently associated with the telomere during S phase to facilitate T loop disassembly. However, attempts to test this possibility have been hampered by the fact that RTEL1 is expressed at very low levels in cells and its overexpression confers cellular toxicity; the former likely explains the absence of RTEL1 in PICh analysis of telomeres (Dé jardin and Kingston, 2009 ).
Function of the SLX4 Resolvasome at Telomeres SLX4 and its associated nucleases MUS81, ERCC1/XPF, and SLX1 were previously shown to associate with telomeres and to colocalize with the shelterin components TRF2 and Rap1 (Fekairi et al., 2009; Svendsen and Harper, 2010; Svendsen et al., 2009) . However, the function of SLX4 at telomeres had not been investigated. In agreement with recent studies implicating SLX4 in Fanconi Anemia, we found that downregulation of SLX4 in mouse cells led to the accumulation of radial chromosomes (Crossan et al., 2011; Stoepker et al., 2011) . However, depletion of SLX4, SLX1, or ERCC1/XPF did not lead to the accumulation of TCs nor result in telomere loss or telomere fragility, suggesting that the SLX4 nuclease complex does not perform a critical role in telomere maintenance. Instead, our results raise the possibility that the SLX4 nuclease complex is located at telomeres to resolve persistent HR intermediates that may arise infrequently in normal cells. In contrast, RTEL1-deficient cells represent the extreme scenario where T loops persist and SLX4 resolvase activity toward these structures leads to catastrophic consequences for telomere integrity.
A General Mechanism of TC Formation in Vertebrate Cells
Our analysis of RTEL1-deficient cells has also revealed phenotypic similarities to ALT cells and to cells overexpressing TRF2DB, including telomere-length heterogeneity and the presence of TCs (Henson et al., 2002 (Henson et al., , 2009 Wang et al., 2004) . We show here that the formation of TCs occurs by a common mechanism as TC formation in ALT cells and in cells overexpressing TRF2DB is also suppressed by blocking DNA replication or downregulation of the SLX4 resolvasome. Our findings that RTEL1-deficient cells and ALT cells share phenotypic characteristics raise the possibility that downregulation of RTEL1 in cancer cells is a prerequisite to the acquisition of ALT. Although the expression status of RTEL1 in ALT cells has not been investigated in any detail, it is intriguing to note that RTEL1 and TERT are susceptibility loci for glioma (Egan et al., 2011; Jenkins et al., 2011; Shete et al., 2009 ), which maintain telomeres by an ALT mechanism (Silvestre et al., 2011) .
Telomere Fragility: The Role of RTEL1 and Telomeric G4-DNA Structures Evidence from fission yeast and vertebrate cells has established that telomeres are problematic structures for DNA replication (Miller et al., 2006; Sfeir et al., 2009 ). Deletion of Taz1 in yeast leads to rapid telomere loss and replication fork stalling within telomere repeats (Ferreira and Cooper, 2001; Miller et al., 2006) . Similarly, mouse cells deficient for TRF1, the vertebrate homolog of Taz1, exhibit fragile telomeres that resemble common fragile sites as both are respectively increased and induced by low doses of aphidicolin (Sfeir et al., 2009) . Telomere fragility manifests as multiple distinct telomere FISH signals at chromosomes ends, which are believed to represent incomplete regions of DNA replication and/or stalled replication forks (Sfeir et al., 2009) . Indeed, reduced replication fork rates and increased fork stalling at telomeres were readily detectable in TRF1-deficient cells (Sfeir et al., 2009) .
Our finding that telomere fragility is exacerbated by treatment with TMPyP4, a G4-DNA-stabilizing drug (Izbicka et al., 1999) , provides in vivo evidence that telomeric G4-DNA structures are a major source of telomere fragility in vertebrates cells, which is in agreement with studies of G4-DNA structures in yeast (Paeschke et al., 2010; Ribeyre et al., 2009) . It has been proposed that TRF1 acts to suppress telomere fragility by recruiting RTEL1 and BLM, which could unwind telomeric G4-DNA structures (Sfeir et al., 2009 (Sfeir et al., 2009) . It is therefore possible that TRF1 independently recruits RTEL1 and BLM via distinct interaction motifs. Alternatively, RTEL1 and BLM may dismantle different telomeric G4-DNA structures that each contribute to telomere fragility ( Figure 7B ).
EXPERIMENTAL PROCEDURES
Isolation of MEFs and Cell Culture Procedures RTEL1 F/+ and RTEL1 F/À mice were as described in Wu et al. (2007) , MUS81
+/À mice were kindly provided by C. McGowan (Dendouga et al., 2005) , and BLM +/À mice by A. Bradley (Luo et al., 2000) . MEFs were isolated from embryonic day (E) 13.5 embryos and immortalized with pBR322 SV40-LT. Immortalized MEFs were cultured in DMEM containing 10% fetal bovine serum. TRF1
F/F cells were kindly provided by T. de Lange (Sfeir et al., 2009) , and WI 38VA13 ALT cells (ECACC) were cultured in DMEM containing 10% FBS. NIH 3T3 mouse cells were infected with pLPC-NMyc, pLPC-NMyc-TRF2, or pLPCNMyc-DeltaB-TRF2 (a gift from T. de Lange) to generate correspondent overexpressing stable cell lines cultured in DMEM containing 10% FBS. Cre-recombination was carried out with Ad5-CMV-Cre adenovirus (Vector Biolabs) for 24, 48, or 96 hr as described by Celli and de Lange (2005) . shRNAs for SLX4, SLX1, and ERCC1 were introduced using three infections at 24 hr intervals with either lentivirus or retrovirus followed by puromycin selection (Table S1 ). Cells were either untreated or treated with aphidicolin (0.2 mM, 0.5 mM, 5 mM), hydroxyurea (3 mM), or TMP y P 4 (10 mM) treatments for 72 hr with a 2 hr of recovery before collection for TMPyP4-treated cells.
Genomic DNA Extraction and TC Amplification MEFs were collected from two to three 10 cm plates at 70% confluence for each condition. gDNA extraction was performed as described by Muñ ozJordá n et al. (2001) . gDNA was double digested by AluI/HinfI restriction enzymes overnight before starting the TCA assay, which was performed as previously described (Zellinger et al., 2007) with minor modifications: Phi29 DNA polymerization (MBI Fermentas) employed a mammalian telomere primer, and Southern blotting used a mammalian telomere probe for hybridization. Southern blot images were captured and quantified with Storm 840 scanner and ImageQuant TL software (Amersham Biosciences).
Metaphase Spreads, FISH, and CO-FISH Metaphase spreads were prepared as previously described (Bayani and Squire, 2005; Wechsler et al., 2011) . After 96 hr of Cre-induction with or without treatment (aphidicolin, TMPyP4, shRNA), MEFs were incubated for 90 min with colcemid prior to harvesting metaphase cells. MEFs were swollen in 0.075 M KCl for 20 min then fixed in methanol/acetic acid (3:1) prior to spreading. FISH was performed as previously described (Lansdorp et al., 1996) using a FITC-(CCCTAA) 3 PNA probe (Bio Synthesis). DNA was counterstained with 4,6-diamidino-2-phenylindole (DAPI) before the last PBS wash and addition of Vectashield mounting media (Vector). For CO-FISH, cells were incubated with 10 mM 5 0 -BrdU:5 0 -BrdC (3:1; Sigma) for 16-20 hr before harvesting.
Following metaphase spreading, BrdU/dC-substituted DNAs were digested with ExoIII (Promega) and then probed with TelG-Cy3 at 1/3000 and TelC-Fitc at 1/500. Digital images were captured with Zeiss Axio Imager M1 microscope with an ORCA-ER camera (Hamamatsu) controlled by Volocity 4.3.2 software (Improvision). Between 25 and 70 images were taken randomly from each condition in order to count the respective phenotypes. Images were corrected for background and merged with Adobe Photoshop. Telomere loss and telomere fragility in each genotype/condition were analyzed for statistical significance by unpaired t test using Prism version 4.0 statistical analyses software.
IF-FISH
RTEL1 floxed cells were infected with Cre-recombinase expressing adenovirus, grown for 96 hr in an 8-well culture slide, and fixed for 10 min at room temperature (RT) in 2% paraformaldehyde. Cells were washed twice for 5 min in PBS, incubated for 30 min in blocking solution (1 mg/ml BSA, 3% goat serum, 0.1% Triton X-100, 1 mM EDTA in PBS), and then incubated with primary antibody against 53BP1 (Novus, 1:1,000) and secondary antibody (Sigma, 1,5000) for 1 hr and 30 min, respectively, in blocking solution with 5 min washes in PBS in-between. After dehydration of the cells, FISH experiments were performed as described above. 
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